TWO SIGMA ADVISERS, LP - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$110,320
-84.9%
19,700
-82.7%
0.00%
-100.0%
Q3 2022$732,000
-24.0%
114,000
-59.4%
0.00%
-33.3%
Q2 2022$963,000
-52.2%
280,700
-0.7%
0.00%
-40.0%
Q1 2022$2,013,000
-1.7%
282,700
+15.0%
0.01%0.0%
Q4 2021$2,048,000
-45.2%
245,900
-54.2%
0.01%
-50.0%
Q3 2021$3,737,000
+363.6%
536,900
+1488.5%
0.01%
+400.0%
Q2 2021$806,000
-67.2%
33,800
-71.6%
0.00%
-71.4%
Q1 2021$2,454,000
+116.4%
119,200
+157.5%
0.01%
+133.3%
Q4 2020$1,134,000
+19.2%
46,300
+37.8%
0.00%0.0%
Q3 2020$951,000
+71.0%
33,600
-71.3%
0.00%
+50.0%
Q2 2020$556,000
+74.3%
116,900
+30.9%
0.00%
+100.0%
Q1 2020$319,000
+19.0%
89,300
+15.1%
0.00%0.0%
Q4 2019$268,000
+5.9%
77,600
+23.2%
0.00%0.0%
Q3 2019$253,000
+67.5%
63,000
+34.6%
0.00%
Q2 2019$151,000
-5.0%
46,800
+101.7%
0.00%
Q1 2019$159,000
+103.8%
23,200
+34.9%
0.00%
Q4 2018$78,000
-45.5%
17,200
-8.5%
0.00%
Q3 2018$143,000
-21.9%
18,800
-11.7%
0.00%
Q2 2018$183,000
+43.0%
21,300
+21.7%
0.00%
Q1 2018$128,000
-64.4%
17,500
-50.7%
0.00%
-100.0%
Q4 2017$360,000
+60.0%
35,500
+153.6%
0.00%0.0%
Q3 2017$225,000
+95.7%
14,000
+37.3%
0.00%
Q2 2017$115,0000.0%10,2000.0%0.00%
Q1 2017$115,000
+16.2%
10,200
+2.0%
0.00%
Q4 2016$99,00010,0000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 14,378,802$342,935,0004.38%
SILVERARC CAPITAL MANAGEMENT, LLC 122,700$2,926,0001.30%
COMMODORE CAPITAL LP 145,453$3,469,0001.21%
Asymmetry Capital Management, L.P. 63,259$1,509,0001.04%
Opaleye Management Inc. 250,000$5,963,0000.99%
Ikarian Capital, LLC 500,000$11,924,0000.96%
HighVista Strategies LLC 44,750$1,068,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 63,915$1,524,0000.68%
Altium Capital Management LP 104,626$2,495,0000.58%
Integral Health Asset Management, LLC 75,000$1,789,0000.49%
View complete list of SERES THERAPEUTICS INC shareholders